Acl moved out of the speculative category when it started to receive revenue from Fonda. Hyact is now a pipeline product that has funding from an existing revenue stream. It's a different ball game now. There is always risk involved, as with anything, but with revenue there is a solid basis for valuation.
Add to My Watchlist
What is My Watchlist?